Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study
Cardiovasc. Diabetol., 14 July 2025 | https://doi.org/10.1186/s12933-025-02846-x
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
BMJ-British Medical Journal, Feb 13 2024, 384 | https://doi.org/10.1136/bmj-2023-076388
Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
